Aktis Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aktis Oncology and other ETFs, options, and stocks.About AKTS
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company was founded by Todd Foley, Patrick Baeuerle and Brian Goodman in August 2020 and is headquartered in Boston, MA.
AKTS Key Statistics
Stock Snapshot
With a market cap of 1.1B, Aktis Oncology(AKTS) trades at $19.94.
On 2026-06-01, Aktis Oncology(AKTS) stock moved within a range of $19.66 to $20.61. With shares now at $19.94, the stock is trading +1.4% above its intraday low and -3.2% below the session's peak.
Trading activity shows a volume of 36.56K, compared to an average daily volume of 145.94K.
The stock's 52-week range extends from a low of $0.04 to a high of $29.16.
The stock's 52-week range extends from a low of $0.04 to a high of $29.16.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.